CNM Publications 2009 to Present

Found 102 results
Author Title Type [ Year(Asc)]
2017
Ikemoto H, Lingasamy P, Willmore A-MAnton, Hunt H, Kurm K, Tammik O, Scodeller P, Simón-Gracia L, Kotamraju VRamana, Lowy AM et al..  2017.  Hyaluronan-binding peptide for targeting peritoneal carcinomatosis.. Tumour Biol. 39(5):1010428317701628.
Mann AP, Scodeller P, Hussain S, Braun GB, Mölder T, Toome K, Ambasudhan R, Teesalu T, Lipton SA, Ruoslahti E.  2017.  Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer's disease.. Nat Commun. 8(1):1403.
Scodeller P, Simón-Gracia L, Kopanchuk S, Tobi A, Kilk K, Säälik P, Kurm K, Squadrito MLeonardo, Kotamraju VRamana, Rinken A et al..  2017.  Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide.. Sci Rep. 7(1):14655.
Toome K, Willmore A-MA, Paiste P, Tobi A, Sugahara KN, Kirsimäe K, Ruoslahti E, Braun GB, Teesalu T.  2017.  Ratiometric in vivo auditioning of targeted silver nanoparticles.. Nanoscale. 9(28):10094-10100.
Hunt H, Simón-Gracia L, Tobi A, Kotamraju VRamana, Sharma S, Nigul M, Sugahara KN, Ruoslahti E, Teesalu T.  2017.  Targeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles.. J Control Release. 260:142-153.
Sharma S, Kotamraju VRamana, Mölder T, Tobi A, Teesalu T, Ruoslahti E.  2017.  Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth.. Nano Lett. 17(3):1356-1364.
Sharma S, Mann AP, Mölder T, Kotamraju VRamana, Mattrey R, Teesalu T, Ruoslahti E.  2017.  Vascular changes in tumors resistant to a vascular disrupting nanoparticle treatment.. J Control Release. 268:49-56.
2016
Simón-Gracia L, Hunt H, Scodeller P, Gaitzsch J, Kotamraju VRamana, Sugahara KN, Tammik O, Ruoslahti E, Battaglia G, Teesalu T.  2016.  iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.. Biomaterials. 104:247-57.
Paasonen L, Sharma S, Braun GB, Kotamraju VRamana, D Y Chung T, She Z-G, Sugahara KN, Yliperttula M, Wu B, Pellecchia M et al..  2016.  New p32/gC1qR Ligands for Targeted Tumor Drug Delivery.. Chembiochem. 17(7):570-5.
Simón-Gracia L, Hunt H, Scodeller PD, Gaitzsch J, Braun GB, Willmore A-MA, Ruoslahti E, Battaglia G, Teesalu T.  2016.  Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy.. Mol Cancer Ther. 15(4):670-9.
Mann AP, Scodeller P, Hussain S, Joo J, Kwon E, Braun GB, Mölder T, She Z-G, Kotamraju VRamana, Ranscht B et al..  2016.  A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries.. Nat Commun. 7:11980.
Yang WHo, Marth JD.  2016.  Protein glycosylation energizes T cells.. Nat Immunol. 17(6):613-4.
Majzoub RN, Wonder E, Ewert KK, Kotamraju VRamana, Teesalu T, Safinya CR.  2016.  Rab11 and Lysotracker Markers Reveal Correlation between Endosomal Pathways and Transfection Efficiency of Surface-Functionalized Cationic Liposome-DNA Nanoparticles.. J Phys Chem B. 120(26):6439-53.
Ewert KK, Kotamraju VRamana, Majzoub RN, Steffes VM, Wonder EA, Teesalu T, Ruoslahti E, Safinya CR.  2016.  Synthesis of linear and cyclic peptide-PEG-lipids for stabilization and targeting of cationic liposome-DNA complexes.. Bioorg Med Chem Lett. 26(6):1618-23.
Willmore A-MA, Simón-Gracia L, Toome K, Paiste P, Kotamraju VRamana, Mölder T, Sugahara KN, Ruoslahti E, Braun GB, Teesalu T.  2016.  Targeted silver nanoparticles for ratiometric cell phenotyping.. Nanoscale. 8(17):9096-101.
King A, Ndifon C, Lui S, Widdows K, Kotamraju VR, Agemy L, Teesalu T, Glazier JD, Cellesi F, Tirelli N et al..  2016.  Tumor-homing peptides as tools for targeted delivery of payloads to the placenta.. Sci Adv. 2(5):e1600349.

Pages